首页> 外文期刊>Majallah-i pizishki-i Urumiyah. >EVALUATION OF THE PROPHYLACTIC ANTIBIOTICS EFFECT ON THE LOW-RISK PATIENTS WHO CANDIDATE FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY
【24h】

EVALUATION OF THE PROPHYLACTIC ANTIBIOTICS EFFECT ON THE LOW-RISK PATIENTS WHO CANDIDATE FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY

机译:评估选择性腹腔镜胆囊切除术对低危患者的预防性抗菌药作用

获取原文
           

摘要

Background & Aims : Cholecystectomy is a most known procedure in patients with gallbladder disease such as choleducolithiasis. This study aimed to study the effect of ampibactam prophylaxy (ampicillin/sulbactam) on the low-risk patients who were candidates for elective laparoscopic cholecystectomy. Materials & Methods: This clinical double blind work study was evaluating the elective laparoscopic cholecystectomy in 160 low-risk patients with choleducolithiasis with informed consent 2010-11. The patients were randomly divided into two groups including group A as study group that received 3gr dose of ampibactam (Jaber-ebne-Hayyan Inc) intravenously and group B as the control group that received 10cc normal saline (N/S). The information about age, sex, weight, body mass index (BMI), routine tests, hospital stay for all patients was collected. The patients during hospitalization and within 30 days after surgery were followed for incidence of infectious complications. Results : According to this study, 1 patient (2.1%) of the intervention group and 2 patients (5.2%) in the control group were infected with the Fisher exact test showed no significant differences between the two groups, and the incidence of infection (P=4.0). In all three cases (9.1%) had an infection in one patient (6.0%) from the intervention group and 2 patients (3.1%) of the control patients had a skin wound infection (P=5.0). (P= 8.0). The infection complications have seen in one pationet in control group after 6 and in 2 patients of study group after 5 day after cholecystectom. The mean duration of hospitalization after cholecystectomy in 80 patients in the intervention group was 2.08 ± 0.28 days versus 2.17 ± 0.4 d in the control group (P=1.0). Conclusion : This study results such as other studies results, don’t demonstrate the efficiency of prophylactic antibiotics in low-risk laparoscopic cholecystectomy. So preferably it's not recommended to prescribe antibiotics in low-risk laparoscopic cholecystectomy conditions.
机译:背景与目的:胆囊切除术是胆囊疾病(例如胆囊结石症)患者最常使用的手术方法。这项研究旨在研究安非他命预防性疗法(氨苄西林/舒巴坦)对低危患者的影响,这些患者可以选择进行腹腔镜胆囊切除术。材料与方法:该临床双盲研究旨在评估160例经知情同意的低危胆管结石患者的选择性腹腔镜胆囊切除术。将患者随机分为两组,分别为A组为研究组,静脉注射3gr剂量的安培他汀(Jaber-ebne-Hayyan Inc),B组为对照组,接受10cc生理盐水(N / S)。收集有关所有患者的年龄,性别,体重,体重指数(BMI),常规检查和住院时间的信息。在住院期间和手术后30天内对患者进行感染并发症发生率的随访。结果:根据这项研究,干预组的1例患者(2.1%)和对照组的2例患者(5.2%)被Fisher精确检验感染,两组之间无显着差异,并且感染的发生率( P = 4.0)。在所有三例病例中(9.1%),干预组的一名患者(6.0%)发生了感染,对照组的两名患者(3.1%)发生了皮肤伤口感染(P = 5.0)。 (P = 8.0)。胆囊切除术后第5天,对照组中1只ation虫出现感染并发症,研究组的2例患者中有2例出现感染并发症。干预组80例胆囊切除术后平均住院时间为2.08±0.28天,而对照组为2.17±0.4 d(P = 1.0)。结论:该研究结果和其他研究结果一样,并未证明预防性抗生素在低危腹腔镜胆囊切除术中的有效性。因此,最好不要在低风险的腹腔镜胆囊切除术中开抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号